New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

College of Nursing Researchers Find a New Solution in Detecting Breast-Cancer Related Lymphedema

December 11, 2013

Viewed as one of the most feared outcomes of breast cancer treatment,
doctors struggle detecting and diagnosing breast-cancer related lymphedema— a condition affecting the lymphatic system and causing psychosocial distress and physical challenges for patients.

Now, a team of researchers led by Mei R. Fu, associate professor of chronic disease management at the College of Nursing, offers supporting evidence for using Bioelectrical Impedance Analysis (BIA) ratios to assess lymphedema. The study, “L-Dex Ratio in Detecting Breast Cancer-Related Lymphedema: Reliability, Sensitivity, and Specificity,” published in Lymphology, argues that because the low frequency electronic current cannot travel through cell membranes, it provides a direct measure of lymph fluid outside the cells. This allows for a more accurate assessment of lymphedema using a Lymphedema Index named L-Dex ratio.

“To lessen breast cancer survivors’ worry about lymphedema development, the BIA may have a role in clinical practice by adding confidence in the detection of arm lymphedema among breast cancer survivors,” says Fu, “even when pre-surgical BIA baseline measures are not available.”

Measuring lymphedema is challenging because most methods cannot distinguish bone and soft tissues from extracellular fluid. BIA is time-efficient, easy to operate, and easy to interpret, making it ideal for clinical practice. Fu’s research collected data from 250 women, including healthy female adults, breast cancer survivors with lymphedema, and those at risk for lymphedema, demonstrating that survivors with lymphedema had significantly higher L-Dex ratios, which shows the possibility of using BIA to discriminate between those cohorts of women.

“Our study also demonstrated that using a more sensitive L-Dex cutoff point allowed for BIA to catch 34 percent of the usually missed lymphedema cases,” says Fu. “This allows for earlier treatment, which naturally leads to better outcomes for at-risk patients.”

The American Cancer Society estimates that in 2013 approximately 232,340 new cases of breast cancer were detected, adding to the already 2.9 million breast cancer survivors, all with a lifetime risk of lymphedema.

“Giving that all the women who are treated for breast cancer are at a lifetime risk for lymphedema, using assessment methods that can accurately identify true lymphedema cases among at-risk breast cancer survivors is of the ultimate importance for clinical practice,” he adds.

The study was supported by the Avon Foundation and the National Institute of Health.

Type: Article

College of Nursing Researchers  Find a New Solution in Detecting  Breast-Cancer Related Lymphedema

Search News

NYU In the News

Paying It Backward: NYU Alum Funds Scholarships

The Wall Street Journal profiled Trustee Evan Chesler on why he decided to chair the Momentum fund-raising campaign.

A Nobel Prize Party: Cheese, Bubbles, and a Boson

The New Yorker talked to Professor Kyle Cranmer and graduate student Sven Kreiss about NYU’s role in the discovery of the Higgs boson, which resulted in a Nobel prize for the scientists who predicted its existence.

The World as They Knew It

The New York Times reviewed the exhibit at the Institute for the Study of the Ancient World on how ancient Greeks and Romans mapped the known and unknown areas of their world.

Elite Institutions: Far More Diverse Than They Were 20 Years Ago

NYU made stronger gains over the last 20 years in increasing diversity than any other major research university, according to the Chronicle of Higher Education.

Program Seeks to Nurture ‘Data Science Culture’
at Universities

The New York Times reported on the multi-million collaboration among NYU and two other universities to harness the potential of Big Data, including an interview with Professor Yann LeCun, director of NYU’s Center for Data Science.

NYU Footer